Why the study?
Does a purely clinical score (CDAI) provide valid disease activity measurement compared to scores including acute phase reactants in rheumatoid arthritis?
Population
Patients with rheumatoid arthritis
Comparison
Clinical Disease Activity Index / purely… vs Scores including acute phase reactants such as…
Design
Other
Authors
Loading...
CDAI may suffice for RA activity assessment without labs; leaves open need for prospective outcome validation.
Does a purely clinical score (CDAI) provide valid disease activity measurement compared to scores including acute phase reactants in rheumatoid arthritis?
A purely clinical score (CDAI) without acute phase reactants is a valid measure of disease activity in rheumatoid arthritis, facilitating immediate treatment decisions.
Aletaha et al. (2005) studied this question.